A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

What the Trained Eye Cannot See: Detecting Movement Defects in Early Stage Parkinson's Disease Aug. 15, 2024 — Using machine learning to analyze video recordings of individuals performing simple ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s DiseaseActive ...

With rising demand and an ageing population, European healthcare systems are under strain. In the second article in our ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

Katie Fagan, Senior Program Coordinator & Clinical Social Worker at Northwestern University Parkinson’s Disease and Movement Disorders Center, joins Lisa Dent to talk about Northwestern Medicine ...

In the past decade, CPP has achieved significant success, including seven regulatory milestones, including the first ...

What the Trained Eye Cannot See: Detecting Movement Defects in Early Stage Parkinson's Disease Aug. 15, 2024 — Using machine learning to analyze video recordings of individuals performing simple ...